Atrial Structural Remodeling as an Antiarrhythmic Target

Beyerbach, 2004, Mortality as an endpoint in atrial fibrillation., Heart Rhythm, 1, 8, 10.1016/j.hrthm.2004.04.018

Nattel, 2006, Controversies in atrial fibrillation., Lancet, 367, 262, 10.1016/S0140-6736(06)68037-9

Nattel, 2006, Innovative approaches to anti-arrhythmic drug therapy., Nat Rev Drug Discov, 5, 1034, 10.1038/nrd2112

Nattel, 2007, Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation., Physiol Rev, 87, 425, 10.1152/physrev.00014.2006

Allessie, 2002, Electrical, contractile and structural remodeling during atrial fibrillation., Cardiovasc Res, 54, 230, 10.1016/S0008-6363(02)00258-4

Silver, 1990, Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis., Cardiovasc Res, 24, 741, 10.1093/cvr/24.9.741

Weber, 1990, Fibrillar collagen and remodeling of dilated canine left ventricle., Circulation, 82, 1387, 10.1161/01.CIR.82.4.1387

Cleutjens, 1995, Collagen remodeling after myocardial infarction in the rat heart., Am J Pathol, 147, 325

Ohtani, 1995, High prevalence of atrial fibrosis in patients with dilated cardiomyopathy., J Am Coll Cardiol, 25, 1162, 10.1016/0735-1097(94)00529-Y

Tsuda, 2003, Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes., Cardiovasc Res, 59, 926, 10.1016/S0008-6363(03)00519-4

Bailey, 1968, Relation of left atrial pathology to atrial fibrillation in mitral valvular disease., Ann Intern Med, 69, 13, 10.7326/0003-4819-69-1-13

Thiedemann, 1977, Left atrial ultrastructure in mitral valvular disease., Am J Pathol, 89, 575

Frustaci, 1991, Cardiac biopsy in patients with primary atrial fibrillation. Histologic evidence of occult myocardial diseases., Chest, 100, 303, 10.1378/chest.100.2.303

Anyukhovsky, 2002, Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis., Cardiovasc Res, 54, 462, 10.1016/S0008-6363(02)00271-7

Anyukhovsky, 2005, Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation., Cardiovasc Res, 66, 353, 10.1016/j.cardiores.2004.10.033

Ehrlich, 2002, Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets., J Cardiovasc Electrophysiol, 13, 399, 10.1046/j.1540-8167.2002.00399.x

Vaziri, 1994, Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study., Circulation, 89, 724, 10.1161/01.CIR.89.2.724

Li, 1999, Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort., Circulation, 100, 87, 10.1161/01.CIR.100.1.87

Spach, 1997, Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias., Pacing Clin Electrophysiol, 20, 397, 10.1111/j.1540-8159.1997.tb06199.x

Shinagawa, 2002, Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs., Circulation, 105, 2672, 10.1161/01.CIR.0000016826.62813.F5

Cha, 2004, Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure., Circulation, 109, 412, 10.1161/01.CIR.0000109501.47603.0C

Burstein, 2008, Atrial fibrosis: mechanisms and clinical relevance for atrial fibrillation., J Am Coll Cardiol, 51, 802, 10.1016/j.jacc.2007.09.064

Schmieder, 2007, Renin-angiotensin system and cardiovascular risk., Lancet, 369, 1208, 10.1016/S0140-6736(07)60242-6

Saygili, 2007, Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes., Am J Physiol Heart Circ Physiol, 292, H2898, 10.1152/ajpheart.00546.2006

Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells., Circ Res, 74, 1141, 10.1161/01.RES.74.6.1141

Sekiguchi, 2004, Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure., Cardiovasc Res, 63, 433, 10.1016/j.cardiores.2004.02.005

Lijnen, 2000, Induction of cardiac fibrosis by angiotensin II., Methods Find Exp Clin Pharmacol, 22, 709, 10.1358/mf.2000.22.10.802287

Goette, 2000, Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation., J Am Coll Cardiol, 35, 1669, 10.1016/S0735-1097(00)00611-2

Tsai, 2004, Renin-angiotensin system gene polymorphisms and atrial fibrillation., Circulation, 109, 1640, 10.1161/01.CIR.0000124487.36586.26

Xiao, 2004, Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death., Am J Pathol, 165, 1019, 10.1016/S0002-9440(10)63363-9

Ehrlich, 2006, Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence., Eur Heart J, 27, 512, 10.1093/eurheartj/ehi668

Cardin, 2003, Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways., Cardiovasc Res, 60, 315, 10.1016/j.cardiores.2003.08.014

Li, 2001, Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure., Circulation, 104, 2608, 10.1161/hc4601.099402

Kumagai, 2003, Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation., J Am Coll Cardiol, 41, 2197, 10.1016/S0735-1097(03)00464-9

Pedersen, 1999, Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction., Circulation, 100, 376, 10.1161/01.CIR.100.4.376

Vermes, 2003, Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials., Circulation, 107, 2926, 10.1161/01.CIR.0000072793.81076.D4

Healey, 2005, Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis., J Am Coll Cardiol, 45, 1832, 10.1016/j.jacc.2004.11.070

Scaglione, 2007, Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients., J Hum Hypertens, 21, 307, 10.1038/sj.jhh.1002161

Lijnen, 2000, Induction of cardiac fibrosis by aldosterone., J Mol Cell Cardiol, 32, 865, 10.1006/jmcc.2000.1129

Mizuno, 2001, Aldosterone production is activated in failing ventricle in humans., Circulation, 103, 72, 10.1161/01.CIR.103.1.72

Sun, 1997, Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion., Cardiovasc Res, 35, 138, 10.1016/S0008-6363(97)00097-7

Milliez, 2005, Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction., Eur Heart J, 26, 2193, 10.1093/eurheartj/ehi478

Hayashi, 2003, Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction., Circulation, 107, 2559, 10.1161/01.CIR.0000068340.96506.0F

Milliez, 2005, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism., J Am Coll Cardiol, 45, 1243, 10.1016/j.jacc.2005.01.015

Shroff, 2006, Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure., J Cardiovasc Electrophysiol, 17, 534, 10.1111/j.1540-8167.2006.00372.x

Lijnen, 2000, Induction of cardiac fibrosis by transforming growth factor-beta(1)., Mol Genet Metab, 71, 418, 10.1006/mgme.2000.3032

Rosenkranz, 2004, TGF-beta1 and angiotensin networking in cardiac remodeling., Cardiovasc Res, 63, 423, 10.1016/j.cardiores.2004.04.030

Lee, 1995, Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts., J Mol Cell Cardiol, 27, 2347, 10.1016/S0022-2828(95)91983-X

Cucoranu, 2005, NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts., Circ Res, 97, 900, 10.1161/01.RES.0000187457.24338.3D

Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis., Nat Med, 13, 952, 10.1038/nm1613

Nakajima, 2000, Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart., Circ Res, 86, 571, 10.1161/01.RES.86.5.571

Verheule, 2004, Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1., Circ Res, 94, 1458, 10.1161/01.RES.0000129579.59664.9d

Hanna, 2004, Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure., Cardiovasc Res, 63, 236, 10.1016/j.cardiores.2004.03.026

Lee, 2006, Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure., Circulation, 114, 1703, 10.1161/CIRCULATIONAHA.106.624320

Armendariz-Borunda, 2006, A pilot study in patients with established advanced liver fibrosis using pirfenidone., Gut, 55, 1663, 10.1136/gut.2006.107136

Azuma, 2005, Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 171, 1040, 10.1164/rccm.200404-571OC

Gahl, 2002, Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome., Mol Genet Metab, 76, 234, 10.1016/S1096-7192(02)00044-6

Walker, 2005, A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis., Mult Scler, 11, 149, 10.1191/1352458505ms1134oa

Cordeiro, 2003, Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome., Gene Ther, 10, 59, 10.1038/sj.gt.3301865

Hori, 1998, Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells., Kidney Int, 53, 1616, 10.1046/j.1523-1755.1998.00908.x

Kuwahara, 2002, Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats., Circulation, 106, 130, 10.1161/01.CIR.0000020689.12472.E0

Munger, 1999, The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis., Cell, 96, 319, 10.1016/S0092-8674(00)80545-0

Siriwardena, 2002, Human antitransforming growth factor beta(2) monoclonal antibody-a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study., Ophthalmology, 109, 427, 10.1016/S0161-6420(01)00997-6

Kagitani, 2004, Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats., J Hypertens, 22, 1007, 10.1097/00004872-200405000-00024

Korantzopoulos, 2003, Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress., Med Sci Monit, 9, RA225

Verheule, 2003, Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation., Circulation, 107, 2615, 10.1161/01.CIR.0000066915.15187.51

Kumagai, 2004, The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model., Cardiovasc Res, 62, 105, 10.1016/j.cardiores.2004.01.018

Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation., Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180

Mihm, 2001, Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation., Circulation, 104, 174, 10.1161/01.CIR.104.2.174

Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation., Circulation, 104, 2886, 10.1161/hc4901.101760

Bruins, 1997, Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia., Circulation, 96, 3542, 10.1161/01.CIR.96.10.3542

Rotter, 2006, Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation., J Am Coll Cardiol, 47, 1231, 10.1016/j.jacc.2005.12.038

Siwik, 2004, Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium., Heart Fail Rev, 9, 43, 10.1023/B:HREV.0000011393.40674.13

Dernellis, 2004, Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation., Eur Heart J, 25, 1100, 10.1016/j.ehj.2004.04.025

Shiroshita-Takeshita, 2006, Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs., Cardiovasc Res, 69, 865, 10.1016/j.cardiores.2005.11.028

Carnes, 2001, Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation., Circ Res, 89, E32, 10.1161/hh1801.097644

Halonen, 2007, Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial., JAMA, 297, 1562, 10.1001/jama.297.14.1562

Shiroshita-Takeshita, 2004, Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs., Circulation, 110, 2313, 10.1161/01.CIR.0000145163.56529.D1

Korantzopoulos, 2004, Anti-inflammatory and antioxidant actions of statins may favorably affect atrial remodeling in atrial fibrillation., Am J Cardiol, 93, 1200, 10.1016/j.amjcard.2003.12.044

Shiroshita-Takeshita, 2007, Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure., Cardiovasc Res, 74, 75, 10.1016/j.cardiores.2007.01.002

Boos, 2006, Is atrial fibrillation an inflammatory disorder?, Eur Heart J, 27, 136, 10.1093/eurheartj/ehi645

Patti, 2006, Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study., Circulation, 114, 1455, 10.1161/CIRCULATIONAHA.106.621763

Korantzopoulos, 2005, The anti-inflammatory and antioxidant effects of long-chain n-3 fatty acids or oil-rich fish may favorably affect atrial remodeling in atrial fibrillation., Med Hypotheses, 64, 1245, 10.1016/j.mehy.2004.12.011

Hu, 2001, Types of dietary fat and risk of coronary heart disease: a critical review., J Am Coll Nutr, 20, 5, 10.1080/07315724.2001.10719008

Albert, 2002, Blood levels of long-chain n-3 fatty acids and the risk of sudden death., N Engl J Med, 346, 1113, 10.1056/NEJMoa012918

Sakabe, 2007, Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling., Circulation, 116, 2101, 10.1161/CIRCULATIONAHA.107.704759

Calo, 2005, N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial., J Am Coll Cardiol, 45, 1723, 10.1016/j.jacc.2005.02.079

Brundel, 2006, Induction of heat shock response protects the heart against atrial fibrillation., Circ Res, 99, 1394, 10.1161/01.RES.0000252323.83137.fe

Shiroshita-Takeshita, 2007, Heat shock protein induction attenuates atrial remodeling and atrial fibrillation promotion in dogs with ventricular tachycardiomyopathy., Circulation, 116, II

Sakabe, 2006, Effects of heat shock protein induction on atrial fibrillation caused by acute atrial ischemia., Circulation, 114, II

Rich, 2003, Endothelin receptor blockers in cardiovascular disease., Circulation, 108, 2184, 10.1161/01.CIR.0000094397.19932.78

Feldman, 2003, The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?, Med Clin North Am, 87, 419, 10.1016/S0025-7125(02)00189-X

Stratton, 2001, Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients., J Clin Invest, 108, 241, 10.1172/JCI12020

Mukherjee, 2006, Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation., Am J Cardiol, 97, 532, 10.1016/j.amjcard.2005.08.073

Nakano, 2004, Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation., J Am Coll Cardiol, 43, 818, 10.1016/j.jacc.2003.08.060

Creemers, 2001, Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?, Circ Res, 89, 201, 10.1161/hh1501.094396

Hudson, 2006, Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial., J Am Coll Cardiol, 48, 15, 10.1016/j.jacc.2006.02.055